Clinicn Investigator, Assc Prf Psychiatry, Mass General Research Institute

Associate Professor of Psychiatry Harvard Medical School

Psychiatrist Psychiatry, Massachusetts General Hospital

MD Universita Di Milano 1997

antidepressive agents; bipolar disorder; depressive disorder major; ketamine; monoamine oxidase; mood disorders; polymorphism genetic; psychopharmacology; receptors dopamine d2; serotonin uptake inhibitors; treatment-resistant depression; tryptophan hydroxylase

Dr. Cusin's field of interest is Treatment Resistant Depression (TRD).

At the Depression Clinical & Research Program (DCRP), she is involved in numerous clinical trials, sponsored by NIMH and foundations, investigating new pharmacologic treatments for Major Depression and TRD, including intravenous administration of ketamine and scopolamine

She is one of the programmers in the pivotal trial for Deep Brain Stimulation for MDD sponsored by Medtronic, for patients affected by extremely treatment-refractory depression.

Dr. Cusin is also developing two original projects aiming at detecting possible neurobiological mechanisms of placebo response in antidepressant clinical trials.